Характеристика и клиническое значение некоторых малоизученных возбудителей рода Chryseobacterium (обзор литературы) Characteristics and clinical significance some little study pathogens of the genus Chryseobacterium: A literature review
Abstract
Some members of Chryseobacterium genus, Flavobacteriaceae spp. are opportunistic microorganisms. They are relatively new and understudied pathogens by Russian scientists while in different European, Asian and other countries they are regarded as potentially hazardous pathogens especially among immunocompromised patients and premature newborns. Literature review evidence that Chryseobacterium microorganisms should be considered as potential pathogens that have wide range of natural drug resistance that defines a unique profile of drug susceptibility. The review presents scientific literature data on the role of most known member of Chryseobacterium in human pathology - Chryseobacterium indologenes.
About the Authors
A. O. Golubeva
FBUN Khabarovsk research institute of epidemiology and microbiology of the Federal service for surveillance on consumers rights protection and human wellbeing (Rospotrebnadzor), Khabarovsk, Russia
Russian Federation
Russian Federation
A. P. Bondarenko
FBUN Khabarovsk research institute of epidemiology and microbiology of the Federal service for surveillance on consumers rights protection and human wellbeing (Rospotrebnadzor), Khabarovsk, Russia
Russian Federation
Russian Federation
O. E. Trotsenko
FBUN Khabarovsk research institute of epidemiology and microbiology of the Federal service for surveillance on consumers rights protection and human wellbeing (Rospotrebnadzor), Khabarovsk, Russia
Russian Federation
Russian Federation
References
1. Боронина Л.Г., Кукушкина М.П., Крутова К.В. и др. Род Chryseobacterium (Flavobacterium): клиническое значение, идентификация, чувствительность к антибиотикам // КМАХ. – 2003. – Т. 5, № 3. – С. 243-250.
2. Боронина Л.Г., Мамаев И.Л., Кукушкина М.П. и др. Антибиотикорезистентность бактерий, вызывающих инфекции новорожденных в реанимационных отделениях / Сборник «Интенсивная терапия в педиатрии». – Екатеринбург, 1999. – C. 7-9.
3. Зубова К. В., Кондратенко О.В., Глинская Е.В. Видовой состав представителей порядка Flavobacteriales, выделенных от пациентов с муковисцидозом в РФ за 2019-2021 гг. / Всероссийский конгресс по медицинской микробиологии, клинической микологии и иммунологии (XXV Кашкинские чтения). – Санкт-Петербург, 2022.
4. Семанин А. Г. Васильев Д. А. Золотухин C.Н. Конструирование дифференциальнодиагностической среды для идентификации и первичной дифференциации бактерий рода Flavobacterium // Вестник Ульяновской государственной сельскохозяйственной академии. – 2018. – Т. 41, №1. – С. 99-108.
5. Семанин A.Г., Пекарская Н.П., Золотухин С.Н. и др. Разработка селективной добавки для выделения возбудителя флавобактериоза / Аграрная наука и образование на современном этапе развития: опыт, проблемы и пути их решения: Материалы VIII Международной научно-практической конференции. – Ульяновск: УГСХА им. П.А. Столыпина, 2017. – Ч. III. – С. 265-267.
6. Хасанова Г.Ф., Мавзютов А.Р., Мирсаяпова И.А. и др. Этиологическое значение и антибиотикочувствительность неферментирующих грамотрицательных бактерий в клинической практике // Медицинский вестник Башкортостана. – 2012. – Т. 7, № 1. – С. 63-65.
7. Aber R.C., Wennersten C., Moellering Jr. R.C. Antimicrobial susceptibility of Flavobacteria // Antimicrob Agents Chemother. – 1978. – № 3, Vol. 14. – P. 483–487.
8. Afshar M., Nobakht E., Lew S.Q. Chryseobacterium indologenes peritonitis in peritoneal dialysis // BMJ Case Rep. – 2013. http://dx.doi.org/10.1136/bcr-2013-009410
9. Alon D., Karniel E., Zohar I. et al. Chryseobacterium indologenes bacteremia: clinical and microbiological characteristics of an emerging infection // Int J Clin Med. – 2018. – № 6, Vol. 9. – P. 520-527.
10. Antonello V.S., Daht P., Polli J. et al. Ventilator-associated pneumonia in neonatal intensive care unit due to Chryseobacterium indologenes // Pediatr Infect Dis J. – 2017. –№ 12, Vol. 36. – Р. 353-355.
11. Arif N., Khullar S., Kumar R. et al. Pleural effusion caused by Chryseobacterium indologenes: a clinical case and review of the literature// J Lab. – 2019. – № 3, Vol.11. – P. 284–286.
12. Aydin Teke T., Oz F.N., Metin O. et al. Chryseobacterium indologenes septicaemia in an infant // Case Rep Infect Dis. – 2014. – № 8, Vol. 2014. – doi:10.1155/2014/270521.
13. Bagely D.H., Alexander J.C., Gill V.J. et al. Late Flavobacterium species meningitis after craniofacial exenteration // Arch Intern Med. – 1976. – № 2, Vol. 136. – P. 229–231.
14. Barrow G.I., Feltham R.K.A. Gowan and Steel’s Manual for the identification of medical bacteria // Cambridge University Press. – 1993. – Vol. 3. – Р.116-117.
15. Bellais S., Léotard S., Poirel L. et al. Molecular characterization of a carbapenem-hydrolyzing beta-lactamase from Chryseobacterium (Flavobacterium) indologenes // FEMS Microbiol Lett. – 1999. –№ 2, Vol. 171. – Р.127-132.
16. Bellais S., Poirel L., Leotard S., P Nordmann. Genetic diversity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium (Flavobacterium) indologenes // Antimicrob Agents Chemother. – 2000. – № 11, Vol. 44. – P. 3028-3034.
17. Bernardet J.F., Nakagawa Y., Holmes B., et al. Proposed minimal standards for describing new taxa of the family Flavobacteriaceae and emended description of the family // International Journal of Systematic and Evolutionary Microbiology. – 2002. – Vol. 52. – Р. 1049 –1070.
18. Bhagawati G., Bhardwaj A., Sajikumar R. et al. Bacteremia by Chryseobacterium indologenes in a Patient with Lung Cancer: A Clinical and Microbiological Investigation // Indian J Crit Care Med. – 2019. – № 3, Vol.23. – P. 157–159.
19. Bhuyar G., Jain S., Shah H., Mehta V.K. Urinary tract infection by Chryseobacterium indologenes // Indian J Med Microbiol. – 2012. – № 3, Vol. 30. – P. 370–372.
20. Bloch K. C., Nadarajah R., Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review // Medicine (Baltimore). – 1997. – № 1, Vol.76. – P. 30–41.
21. Bonten M.J., van Tiel F.H., van der Geest S. et al. Topical antimicrobial prophylaxis of nosocomial pneumonia in mechanically ventilated patients // Microbiological observations Infection. – 1993. – № 3, Vol. 21. – P. 137–139.
22. Brown R.B., Phillips D., Barker M.J. et al. Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B // Am J Infect Control. – 1989. – № 3, Vol.17. – P. 121-125.
23. Calderón G., García E., Rojas P. et al. Chryseobacterium indologenes infection in a newborn: a case report // J Med Case Rep. – 2011. – Vol. 5. – Р.10.
24. Cantero M., Parra L.M., Munez E. et al. A cluster of Chryseobacterium indologenes cases related to drainage water in intensive care units // Infect Control Hosp Epidemiol. – 2018. – № 8, Vol 39. – Р. 997-999.
25. Chang Y.C., Lo H.H., Hsieh H.Y. et al. Identification, epidemiological relatedness, and biofilm formation of clinical Chryseobacterium indologenes isolates from central Taiwan // J Microbiol Immunol Infect. – 2015. – № 5, Vol. 48. – Р. 559-564.
26. Chen F.L., Wang G.C., Teng S.O. et al. Clinical and epidemiological features of Chryseobacterium indologenes infections: Analysis of 215 cases // J Microbiol Immunol Infect. – 2013. – № 6, Vol. 46. – P. 425 – 432.
27. Choi M.W., Oh S.S., Choi M.R. et al. Chryseobacterium indologenes // Kor J Med. – 2018. – № 1, Vol.93. – P. 65–67.
28. Choi M.W., Oh S.S., Choi M.R. et al. Peritoneal Dialysis-associated Peritonitis Caused by Chryseobacterium indologenes // Korean J Med. – 2018. – №1, Vol. 93. – P. 65-67.
29. Chou D.W., Wu S.L., Lee C.T. et al. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit // Jpn J Infect Dis. – 2011. – № 6, Vol.64. – P. 520-524.
30. Christakis G.B., Perlorentzou S.P., Chalkiopoulou I. et al. Chryseobacterium indologenes noncatheter-related bacteremia in a patient with a solid tumor // J Clin Microbiol. – 2005. – № 4, Vol. 43. – P. 2021– 2023.
31. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. In: 17th informational supplement. CLSI Document M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
32. Corbella M., Brandolini M., Cambieri P. et al. A catheter-related bloodstream infection caused by Chryseobacterium indologenes successfully treated with antibiotic-lock rescue therapy // New Microbiol. – 2017. – № 3, Vol. 40. – P. 223–225.
33. Cunha V., Ferreira M., Fonseca A. et al. Community-acquired Chryseobacterium indologenes in an immunocompetent patient // JMM Case Rep. – 2014. – № 1, Vol. 1. – Р.1-2.
34. Douvoyiannis M., Kalyoussef S., Philip G. Chryseobacterium indologenes bacteremia in an infant // Int J Infect Dis. – 2010. –№ 6, Vol. 14. – Р. 531–532.
35. Du Moulin G.C. Airway colonization by Flavobacterium in an intensive care unit // J. Clin. Microbiol. – 1979. – № 2, Vol. 10. – P. 155–160.
36. Esposito S., Russo E., De Simone G. et al. Transient bacteraemia due to Chryseobacterium indologenes in an immunocompetent patient: a case report and literature review // J Chemother. – 2015. –№ 6, Vol. 27. – Р. 324-329.
37. Ferreira R.S., Brandao F.F., Lobo S.M. Chryseobacterium indologenes infection: a case report // Rev Bras Ter Intensiva. – 2010. –№ 1, Vol. 22. – Р. 96–98.
38. Fraser S. L., Jorgensen J. H. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing // Antimicrob Agents Chemother. – 1997. – № 12, Vol. 41. – P. 2738–2741.
39. González-Castro A., Alsasua A., Peñasco Y. et al. Tracheo-bronchitis and pneumonia associated with mechanical ventilation by Chryseobacterium indologenes // Rev Esp Anestesiol Reanim. – 2017. –№ 5, Vol. 64. – Р. 294-298.
40. Green B.T., Nolan P.E. Cellulitis and bacteraemia due to Chryseobacterium indologenes // J.Infect. – 2001. –№ 3, Vol. 42. – Р. 219–220.
41. Hantsis-Zacharov E., Shakéd T., Senderovich Y. et al. Chryseobacterium oranimense sp. nov., a psychrotolerant, proteolytic and lipolytic bacterium isolated from raw cow's milk // International Journal of Systematic and Evolutionary Microbiology. – 2008. – Vol. 58. – Р. 2635–2639.
42. Hirsh B. E., Wong B., Kiehn T. E. et al. Flavobacterium meningosepticum bacteremia in an adult with acute leukemia. Use of rifampin to clear persistent infection // Diagn Microbiol Infect Dis. – 1986. – № 1, Vol. 4. – P. 65-69.
43. Hoque S.N., Graham J., Kaufmann M. E., Tabaqchali S. Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit // J Hosp Infect. – 2001. – № 3, Vol. 47. – P. 188-192.
44. Holmes B., Owen R.J., Steigerwalt A.G. et al. Flavobacterium gleum, a new species found in human clinical specimens // Int J Syst Bacteriol. – 1984. – № 1, Vol. 34. – Р.21–25.
45. Hsueh P.R., Hsiue T.R., Wu J.J. et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics // Clin Infect Dis. – 1996. – № 3, Vol. 23. – P. 550 – 555.
46. Hsueh P.R., Teng L.J., Ho S.W. et al. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices // J. Clin Microbiol. – 1996. – № 8, Vol. 34. – P. 1908–1913.
47. Hsueh P. R., Teng L. J., Yang P. C. et al. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan // Eur J Clin Microbiol Infect Dis. – 1997. – № 8, Vol. 16. – P. 568–574.
48. Izaguirre-Anariba D. E., Sivapalan V. Chryseobacterium indologenes, an Emerging Bacteria: A Case Report and Review of Literature // Cureus. – 2020. – № 1, Vol.12. – P.1-7.
49. Kim K.K., Kim M.K., Lim J.H. et al. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. // International Journal of Systematic and Evolutionary Microbiology. – 2005. – Vol. 55. – Р. 1287–1293.
50. Kirby J.T., Saderm H.S., Walsh T.R. et al. Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001) // J Clin Microbiol. – 2004. – № 1, Vol. 42. – P. 445 – 448.
51. Lambiase A., Del Pezzo M., Raia V. et al. Chryseobacterium respiratory tract infections in patients with cystic fibrosis // J Infect. – 2007. –№ 6, Vol 55. – Р. 518-523.
52. Liang C.Y., Yang C.H., Lai C.H. et al. Genomic features, comparative genomic analysis, and antimicrobial susceptibility patterns of Chryseobacterium arthrosphaerae strain ED882-96 isolated in Taiwan // Genes. – 2019. –№ 4, Vol. 10. – Р. 309.
53. Lin J.N., Lai C.H., Yang C.H. et al. Differences in clinical manifestations, antimicrobial susceptibility patterns, and mutations of fluoroquinolone target genes between Chryseobacterium gleum and Chryseobacterium indologenes // Antimicrob Agents Chemother. – 2019. –№ 5, Vol. 63. doi: 10.1128/AAC.02256-18
54. Lin Y.T., Chan Y.J., Chiu C.H. et al. Tigecycline and colistin susceptibility of Chryseobacterium meningosepticum isolated from blood in Taiwan // Int J Antimicrob Agents. – 2009. – № 1, Vol.34. – P. 100-101.
55. Lin Y.T., Jeng Y.Y., Lin M.L. et al. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia // J Microbiol Immunol Infect. – 2010. – № 6, Vol. 43. – P. 498-505.
56. Loch T.P., Faisal M. Emerging flavobacterial infections in fish: A review // Journal of Advanced Research. – 2015. – № 3, Vol. 6. – Р. 283–300.
57. Matsumoto T., Nagata M., Ishimine N. et al. Characterization of CIA-1, an Ambler class A extended-spectrum β-lactamase from Chryseobacterium indologenes // Antimicrob Agents Chemother. – 2012. – № 1, Vol. 56. – P. 588-590.
58. Matu A., Lum Nde A., Oosthuizen L., Hitzeroth A. et al. Draft Genome Sequences of Seven Chryseobacterium Type Strains // Microbiol Resour Announc. 2019. – № 1, Vol. 8. – Р. e01518-18.
59. Mirza H.C., Tuncer O., Olmez S. et al. Clinical strains of Chryseobacterium and Elizabethkingia spp. isolated from pediatric patients in a university hospital: performance of MALDI-TOF MS-based identification, antimicrobial susceptibilities, and baseline patient characteristics // Microb Drug Resist. – 2018. –№ 6, Vol. 24. – Р. 816-821.
60. Mukerji R., Kakarala R., Smith S.J., Kusz H.G. . Chryseobacterium indologenes: an emerging infection in the USA // BMJ Case Rep. – 2016. – bcr2016214486.
61. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. NCCLS Document M100-S4. – 2002. – Vol. 22, №1.
62. Nulens E., Bussels B., Bols A. et al. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravenous device // Clin Microbiol Infect. – 2001. – № 7, Vol. 7. – P. 391-393.
63. Page A.P., Roberts M., Félix M.A. et al. The golden death bacillus Chryseobacterium nematophagum is a novel matrix digesting pathogen of nematodes // BMC Biology. – 2019. – № 1, Vol. 17. – Р.10.
64. Palewar M.S., Mudshingkar S.S., Dohe V. et al. Infection by multidrug-resistant Chryseobacterium indologenes in cases of obstructive uropathy: case series with short review // Medical Journal of Dr. DY Patil Vidyapeeth. – 2017. – №4, Vol.10. – P. 376-380.
65. Pan H.J., Teng L.J., Chen Y.C. et al. High protease activity of Chryseobacterium indologenes isolates associated with invasive infection // J Microbiol Immunol Infect. – 2000. – № 4, Vol.33. – P. 223-226.
66. Perilli M., Caporale B., Celenza G. et al. Identification and characterization of a new metallobeta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes // Antimicrob Agents Chemother. – 2007. – № 8, Vol. 51. – P. 2988-2990.
67. Pickett M.J. Methods for identification of flavobacteria // J Clin Microbiol. – 1989. – № 10, Vol. 27. – Р. 2309-2315.
68. Pokrywka M., Viazanko K., Medvick J. et al. A Flavobacterium meningosepticum outbreak among intensive care patients // Am J Infect Control. – 1993. – № 3, Vol. 21. – Р.139-145.
69. Schreckenberger P.C., von Gravenitz A. Acinetobacter, Achromobacter, Alcaligenes, Moraxella, Methylobacterium, and other nonfermentative Gram-negative rods // Manual of Clinical Microbiology. – 1999. – Vol. 7. – Р. 539-560.
70. Shivananda P.G. An unusual case of Flavobacterium meningosepticum pneumonia in an immunocompromised patient // Indian J Pathol Microbiol. – 1999. – № 4, Vol. 42. – Р. 491-492.
71. Siegman-Igra Y., Schwartz D., Soferman G., Konforti N. Flavobacterium group II b bacteremia: report of a case and review of Flavobacterium infections // Med Microbiol Immunol. – 1987. – № 2, Vol. 176 – P.103–111.
72. Spangler S.K., Visalli M.A., Jacobs M.R., Appelbaum P.C. Susceptibilities of nonPseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, dofloxacin, sparfloxacin, cef- tazidime, piperacillin, piperacillin-tazobactam, trimetho- prim-sulfamethoxazole, and imipenem // Antimicrob Agents Chemother. – 1996. – № 3, Vol. 40. – Р. 772-775.
73. Srinivasan G., Muthusamy S., Raveendran V. et al. Unforeseeable presentation of Chryseobacterium indologenes infection in a paediatric patient // BMC Res Notes. – 2016. – Vol. 9. – Р. 212.
74. Stamm W.E., Colella J.J., Anderson R.L., Dixon R.E. Indwelling arterial catheters as a source of nosocomial bacteremia: an outbreak caused by Flavobacterium species // N Engl J Med. – 1975. – № 21, Vol. 292. – P. 1099-1102.
75. Steinberg J.P., Del Rio C. Other Gram-negative bacilli // Principles and Practice of Infectious Diseases. – 2000. – Vol. 5. – Р. 2466-2467.
76. Sudharani V., Asiya, Saxena N.K. Chryseobacterium indologenes bacteremia in a preterm baby // Indian J Med Microbiol. – 2011. – № 2, Vol. 29. – P. 196-198.
77. Tekerekoglu M.S., Durmaz R., Ayan M. et al. Analysis of an outbreak due to Chryseobacterium meningosepticum in a neonatal intensive care unit // New Microbiol. – 2003. – № 1, Vol. 26. – Р. 57-63.
78. Vandamme P., Bernardet J.F., Segers P. et al. New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacternom. rev. // Int J Syst Bacteriol. – 1994. –№ 4, Vol. 44. – P. 827–831.
79. Vaneechoutte M., Dijkshoorn L., Nemec A. et al. Acinetobacter, Chryseobacterium, Moraxella, and other nonfermentative Gram-negative rods J. Versalovic (Ed.) // Manual of clinical microbiology. – 2011. – Vol.10. – P. 714-738.
80. Visalli M. A., Bajaksouzian S., Jacobs M. R., Appelbaum P.C. Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods // Antimicrob Agents Chemother. – 1997. – № 7, Vol. 41. – P. 1475-1481.
81. Yabuuchi E., Hashimoto Y., Ezaki T. et al. Genotypic and phenotypic differentiation of Flavobacterium indologenes Yabuuchi et al 1983 from Flavobacterium gleum Holmes et al 1984 // Microbiol Immunol. – 1990. – Vol. 34. – Р. 73–76.
82. Yabuuchi E., Kaneko T., Yano I. et al. Sphingobacterium gen. nov., Sphingobacterium spiritivorum comb. nov., Sphingobacterium multivorum comb.nov., Sphingobacterium mizutae sp.nov., and Flavobacterium indologenes sp. nov.: glucose-nonfermenting, gram-negative rods in CDC group IIk-2 and IIb. // Int J Syst Bacteriol. – 1983. – № 3, Vol. 33. – Р. 580–598.
83. Yamaguchi Y., Takashio N., Wachino J. et al. Structure of metallo-beta-lactamase IND-7 from a Chryseobacterium indologenes clinical isolate at 1.65-A resolution // J Biochem. – 2010. – № 6, Vol. 147. – P. 905-915.
84. Zeba B., De Luca F., Dubus A. et al. IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso // Antimicrob Agents Chemother. – 2009. – № 10, Vol. 53. – P. 4320-4326.
85. Zhang Y., Li D., Yang Y. et al. Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in Shanghai, China // Journal Annals of Translational Medicine. – 2021. – № 8, Vol 9. – Р. 668.
Review
For citations:
Golubeva A.O., Bondarenko A.P., Trotsenko O.E. Характеристика и клиническое значение некоторых малоизученных возбудителей рода Chryseobacterium (обзор литературы) Characteristics and clinical significance some little study pathogens of the genus Chryseobacterium: A literature review. Far Eastern Journal of Infectious Pathology. 2023;(44):86-98. (In Russ.)
Views:
21
Email this article 